Absci Corp (ABSI)
Absci Corp (ABSI) from its SEC filings: 2025 revenue $2.8 million (-38% vs the year before), net margin -4114%, free cash flow -$94.0 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Services-Commercial Physical & Biological Research |
| Revenue (2025) | $2.8 million |
| Revenue growth | -38% |
| Net income | -$115.2 million |
| Net margin | -4113.7% |
| Free cash flow | -$94.0 million |
| Diluted EPS | $-0.84 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -46% |
| Cash | $107.9 million |
| Long-term debt | $4.0 million |
| Share count, 1 year | +15% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.